Stay Vigilant When Prescribing Fentanyl

You’ll see more focus on safe use of transdermal and transmucosal fentanyl products.

Issues continue to crop up with fentanyl patches.

Plus there are now updated Risk Evaluation and Mitigation Strategies (REMS) requirements for transmucosal immediate-release fentanyl (TIRF) products (Actiq, Fentora, etc)...partly to ensure they’re only used in opioid-tolerant patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote